Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
The Journal of Trauma and Acute Care Surgery|November 24, 2020
Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?Christopher D Barrett, Hunter B Moore, Navin Vigneshwar, et al.Journal of the American College of Surgeons|May 20, 2017
Viscoelastic Tissue Plasminogen Activator Challenge Predicts Massive Transfusion in 15 MinutesHunter B Moore, Ernest E Moore, Michael P Chapman, et al.Surgery|June 26, 2014
A principal component analysis of postinjury viscoelastic assays: clotting factor depletion versus fibrinolysisTheresa L Chin, Ernest E Moore, Hunter B Moore, et al.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 25, 2010
Application of the HeartLander crawling robot for injection of a thermally sensitive anti-remodeling agent for myocardial infarction therapyMichael P Chapman, Jose L Lopez Gonzalez, Brina E Goyette, et al.Journal of the American College of Surgeons|April 5, 2015
Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhageHunter B Moore, Ernest E Moore, Eduardo Gonzalez, et al.Shock (Augusta, Ga.)|July 30, 2014
Hemolysis exacerbates hyperfibrinolysis, whereas platelolysis shuts down fibrinolysis: evolving concepts of the spectrum of fibrinolysis in response to severe injuryHunter B Moore, Ernest E Moore, Eduardo Gonzalez, et al.The Journal of Trauma and Acute Care Surgery|November 22, 2013
Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapyMichael P Chapman, Ernest E Moore, Christopher R Ramos, et al.American Journal of Surgery|September 28, 2017
The hypercoagulability paradox of chronic kidney disease: The role of fibrinogenGeoffrey R Nunns, Ernest E Moore, Michael P Chapman, et al.Shock (Augusta, Ga.)|March 19, 2015
Combat: Initial Experience with a Randomized Clinical Trial of Plasma-Based Resuscitation in the Field for Traumatic Hemorrhagic ShockMichael P Chapman, Ernest E Moore, Theresa L Chin, et al.Surgery|May 17, 2015
Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shockHunter B Moore, Ernest E Moore, Peter J Lawson, et al.Pageof 4